- $3.61bn
- $11.03bn
- $6.22bn
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary
Brief: Complaint Filed Against Organon Board, Sun Pharma USA, Sun Pharma America- SEC Filing
Organon wins US approval to widen use of arthritis biosimilar drug
Health Rounds: Widely used asthma drug may improve performance of cancer immunotherapies (updated)
Health Rounds: Widely used asthma drug may improve performance of cancer immunotherapies
India's overseas M&A rush risks official ire
India's overseas M&A rush risks official ire
Media: Sun Pharma explores funding mix for $12 billion Organon deal - Bloomberg News
India File: Homegrown companies are making bolder global bets
Organon Q1 revenue and adjusted EPS miss estimates
Brief: Organon Q1 Adjusted EPS USD 0.71 Vs. IBES Estimate USD 0.83
Analysts see growth upside for India's Sun Pharma, flag higher leverage post Organon deal
U.S. RESEARCH ROUNDUP-Commvault Systems, Domino's Pizza, Organon & Co
Corrected: BREAKINGVIEWS-Indian pharma’s US bet hinges on easy turnaround
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton